Kidney cancer is the sixth most common cancer in adults in the UK, with approximately 13 900 new cases every year.1 Kidney cancer incidence rates have almost doubled since the 1990s and are projected to rise further by 2040.2 5-year relative survival for kidney cancer in the UK is below the European average,3 and there is wide variation in provision of kidney cancer care in England and Wales.4 If found early, kidney cancer can be cured, but early diagnosis is challenging as most people (87%) in the UK with stage 1a disease are diagnosed incidentally, having no relevant symptoms.
The Lancet Oncology published a clinical update in Oncology on 19 Mar 2026.
The item focuses on NICE 2026 guideline for the diagnosis and management of kidney cancer.
Review the original article for the full source wording and details.